Specifically, the rates for Suboxone tablets were roughly eight times greater ( please read here).

FORBES: Reckitt's Suboxone Strategy Is Really About Patients Or Profits?

Meanwhile, Reckitt has gradually raised the price of Suboxone Tablets in order to switch patients.

FORBES: Reckitt's Suboxone Strategy Is Really About Patients Or Profits?

The authors believe that this further stigmatized methadone and Suboxone use and that many opportunities to provide science-based information were missed.

CNN: Did rehab fail McCready?

The patent on Suboxone tablets, in fact, expired two years ago, while patent on Suboxone Film expires in 2022, according to the Reckitt spokesman.

FORBES: Reckitt's Suboxone Strategy Is Really About Patients Or Profits?

Meanwhlie, Reckitt will continue to sell both versions of Suboxone.

FORBES: Reckitt's Suboxone Strategy Is Really About Patients Or Profits?

Late last month, Reckitt Benckiser created a stir by unexpectedly announcing that its Suboxone tablet for treating opioid dependence will be withdrawn from the US market sometime over the next six months.

FORBES: Reckitt's Suboxone Strategy Is Really About Patients Or Profits?

With the development of Suboxone Film, the company was able to introduce child resistant, unit-dose packaging with the same active ingredient before it was able to identify and resolve the packaging issues experienced with Suboxone Tablets.

FORBES: Reckitt's Suboxone Strategy Is Really About Patients Or Profits?